Cellular GWAS of the host-pathogen interaction in melioidosis
类鼻疽中宿主与病原体相互作用的细胞 GWAS
基本信息
- 批准号:9371825
- 负责人:
- 金额:$ 23.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-26 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alveolar MacrophagesAntimicrobial ResistanceAustraliaBacteremiaBacteriaBacterial InfectionsBiological AssayBreathingBurkholderia pseudomalleiCandidate Disease GeneCellsCessation of lifeDataDevelopmentDiseaseEnvironmentEnvironmental ExposureExposure toFailureGenesGeneticGenetic DeterminismGenetic ScreeningGenetic VariationGenomeGenomicsGenotypeHeritabilityHost DefenseHumanHuman BiologyHuman Herpesvirus 4Immune responseIn VitroIndividualInfectionInfection preventionIngestionInnate Immune ResponseInvadedInvestigationKnowledgeLigandsLymphocyteMelioidosisModelingNatural ImmunityOutcomePatientsPhenotypePneumoniaPredispositionPublic HealthReportingResearchResearch PersonnelSalmonellaSepsisSoilSoutheastern AsiaStructureTestingVaccinesVariantWhole BloodWorkbasecohortcombatexome sequencingexperiencegenetic associationgenetic variantgenome wide association studygenomic dataimprovedin vivoinnovationinter-individual variationlymphoblastoid cell linemonocytemortalitynovelpathogenprogramstooltraittreatment strategy
项目摘要
Melioidosis is a tropical infection caused by inoculation, inhalation, or ingestion of the Gram-negative soil
saprophyte and Tier 1 select agent Burkholderia pseudomallei. Disease is often severe and treatment is
hampered by difficulty eradicating the pathogen due to its extensive antimicrobial resistance. Pneumonia and
bacteremia are common presentations and often result in sepsis and multi-organ failure. The overall
melioidosis mortality rate is 40% in southeast Asia and 20% in northern Australia. No vaccine is available and
efforts to reduce environmental exposure to the bacterium have been challenging. Although the distribution of
B. pseudomallei in the environment is not fully determined, recent modeling work suggests that it may be
widespread and that an extraordinary 165,000 cases of human melioidosis and 89,000 deaths occur annually
worldwide. Studies show that there is marked inter-individual variation in the whole blood innate immune
response to bacterial ligands in vitro. There is also significant inter-individual variation in the ability of B.
pseudomallei to enter and replicate in primary human cells such as alveolar macrophages and monocytes.
Remarkably, it has been reported that the heritability – or proportion of the observed phenotype explained by
genetic factors – of Salmonella invasion of cells exceeds 50%. Combined, this suggests that naturally
occurring phenotypic variation in vitro can be exploited to identify variants in genes that regulate host defense
against invading bacteria such as B. pseudomallei. EBV-transformed lymphoblastoid cell lines (LCLs) derived
from extensively genotyped and sequenced individuals in the HapMap/100 Genomes Projects are a useful tool
for in vitro screening of genetic regulators of disease-related traits. In vitro phenotypes can be merged with
readily available and unparalleled genomic structure data to perform cellular genome wide association studies
(GWAS) efficiently and cheaply. LCLs infected with B. pseudomallei demonstrate differential invasion and
replication dynamics. This likely reflects significant heritability in the host response to infection, and indicates
that LCL-based cellular GWAS can be effectively used to study modulators of host defense in melioidosis.
Understanding the host determinants of successful B. pseudomallei invasion and replication within cells is
crucial to developing strategies to prevent infection with this resourceful pathogen. The hypothesis of this
project is that novel host genetic variation modulates the dynamics of host cell invasion in melioidosis and that
these genetic modulators can be identified by performing cellular GWAS of quantitative LCL phenotypes. The
aims of this project are to 1) identify genetic determinants of B. pseudomallei invasion and survival in
lymphoblastoid cell lines and 2) validate observed genetic associations in primary human lymphocytes and
monocytes. This exploratory project offers exciting potential to open up new avenues of knowledge about host
defense in melioidosis. Such new knowledge is essential to tackle this increasingly global public health threat.
类鼻疽是一种由接种、吸入或摄入革兰氏阴性土壤引起的热带感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Eoin West其他文献
Timothy Eoin West的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Eoin West', 18)}}的其他基金
Regulation of host inflammatory responses and outcome in melioidosis by TLR5
TLR5 对类鼻疽中宿主炎症反应和结果的调节
- 批准号:
8273969 - 财政年份:2012
- 资助金额:
$ 23.24万 - 项目类别:
Regulation of host inflammatory responses and outcome in melioidosis by TLR5
TLR5 对类鼻疽中宿主炎症反应和结果的调节
- 批准号:
8843030 - 财政年份:2012
- 资助金额:
$ 23.24万 - 项目类别:
Regulation of host inflammatory responses and outcome in melioidosis by TLR5
TLR5 对类鼻疽中宿主炎症反应和结果的调节
- 批准号:
9057608 - 财政年份:2012
- 资助金额:
$ 23.24万 - 项目类别:
Regulation of host inflammatory responses and outcome in melioidosis by TLR5
TLR5 对类鼻疽中宿主炎症反应和结果的调节
- 批准号:
8469901 - 财政年份:2012
- 资助金额:
$ 23.24万 - 项目类别:
Regulation of host inflammatory responses and outcome in melioidosis by TLR5
TLR5 对类鼻疽中宿主炎症反应和结果的调节
- 批准号:
8661279 - 财政年份:2012
- 资助金额:
$ 23.24万 - 项目类别:
Pulmonary Pathogen-Recognition Pathways in Melioidosis
类鼻疽中的肺部病原体识别途径
- 批准号:
8197455 - 财政年份:2008
- 资助金额:
$ 23.24万 - 项目类别:
Pulmonary Pathogen-Recognition Pathways in Melioidosis
类鼻疽中的肺部病原体识别途径
- 批准号:
8014917 - 财政年份:2008
- 资助金额:
$ 23.24万 - 项目类别:
Pulmonary Pathogen-Recognition Pathways in Melioidosis
类鼻疽中的肺部病原体识别途径
- 批准号:
8389612 - 财政年份:2008
- 资助金额:
$ 23.24万 - 项目类别:
Pulmonary Pathogen-Recognition Pathways in Melioidosis
类鼻疽中的肺部病原体识别途径
- 批准号:
7571767 - 财政年份:2008
- 资助金额:
$ 23.24万 - 项目类别:
Pulmonary Pathogen-Recognition Pathways in Melioidosis
类鼻疽中的肺部病原体识别途径
- 批准号:
7743090 - 财政年份:2008
- 资助金额:
$ 23.24万 - 项目类别:
相似海外基金
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响
- 批准号:
BB/Y003861/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Engineering Nature-based Solutions to Tackle Antimicrobial Resistance
工程基于自然的解决方案来解决抗菌素耐药性
- 批准号:
EP/Y003101/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
The epidemiology of transmissible antimicrobial resistance among Shigella species
志贺菌属中传播性抗菌药物耐药性的流行病学
- 批准号:
MR/X000648/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Active one health surveillance in LMICs to monitor and predict Antimicrobial Resistance Using Metagenomics (ALARUM)
在中低收入国家中开展主动单一健康监测,利用宏基因组学 (ALARUM) 监测和预测抗菌药物耐药性
- 批准号:
MR/Y034287/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
A novel anti-biofilm peptide from fish for the combat against antimicrobial resistance
一种来自鱼类的新型抗生物膜肽,用于对抗抗菌素耐药性
- 批准号:
MR/Y503393/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Intended and unintended consequences of the ZnO ban from pig diets on antimicrobial resistance, post-weaning diarrhoea and the microbiome.
猪日粮中禁用氧化锌对抗菌素耐药性、断奶后腹泻和微生物组的有意和无意的影响。
- 批准号:
BB/Y004108/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
A Cell-Free Toolbox to Anticipate, Learn and Counter Antimicrobial Resistance
预测、学习和对抗抗菌素耐药性的无细胞工具箱
- 批准号:
BB/Y005074/1 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Research Grant
Roles of emerging pollutants in spreading antimicrobial resistance
新出现的污染物在传播抗菌素耐药性方面的作用
- 批准号:
DE240100842 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别:
Discovery Early Career Researcher Award
Environmental Reservoirs and Antimicrobial Resistance in Non-tuberculosis Mycobacteria: A Genomic Investigation
非结核分枝杆菌的环境储库和抗菌素耐药性:基因组研究
- 批准号:
502471 - 财政年份:2024
- 资助金额:
$ 23.24万 - 项目类别: